DoW Parkinson’s, Early Investigator Research Award
Defense Health Agency Contracting Activity - DHACA
Want a reminder before this closes?
We'll email you 3 days before the deadline. One email, then we stop.
Free. Verify your email, then we send one reminder only.
- Posted
- Jun 18, 2026
- Amount
- Program total $4.2M
- Closes
- Nov 6, 2026
Similar opportunities open now
- DoW Parkinson’s, Investigator-Initiated Research AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses Nov 6, 2026
- DoW Bone Marrow Failure, Investigator-Initiated Research AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses Nov 4, 2026
- DoW Spinal Cord Injury, Clinical Trial AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses Nov 12, 2026
- DoW Bone Marrow Failure, Idea Development AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses Nov 4, 2026
- DoW Rare Cancers Idea Development AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses Nov 18, 2026 (in 18 days)
Classification and identifiers
- Solicitation number
- HT942526PRPEIRA
- Assistance listing (CFDA)
- 12.420
Amount
Program total $4.2M
Who can apply
About this opportunity
Summary: The fiscal year 2026 (FY26) Parkinson’s Research Program (PRP) Early Investigator Research Award (EIRA) supports Parkinson’s disease (PD) research for investigators in the early stages of their careers. The FY26 EIRA offers two funding levels, which align to the research career stage of the Principal Investigator (PI). Funding Level 1 (for fellows) requires the investigator to receive guidance from a designated Mentor, whereas Funding Level 2 (for early-career independent investigators) does not. Proposed research must address at least one of the four FY26 PRP Focus Areas . Distinctive Features: · The Early Investigator is considered the PI of the application and must exhibit strong potential for and commitment to pursuing a career as an investigator at the forefront of PD researc...